Cargando…

Blood glucose may be an alternative to cholesterol in CVD risk prediction charts

BACKGROUND: Established risk models for the prediction of cardiovascular disease (CVD) include blood pressure, smoking and cholesterol parameters. The use of total cholesterol for CVD risk prediction has been questioned, particularly for primary prevention. We evaluated whether glucose could be used...

Descripción completa

Detalles Bibliográficos
Autores principales: Braun, Julia, Bopp, Matthias, Faeh, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599220/
https://www.ncbi.nlm.nih.gov/pubmed/23351551
http://dx.doi.org/10.1186/1475-2840-12-24
_version_ 1782262913790115840
author Braun, Julia
Bopp, Matthias
Faeh, David
author_facet Braun, Julia
Bopp, Matthias
Faeh, David
author_sort Braun, Julia
collection PubMed
description BACKGROUND: Established risk models for the prediction of cardiovascular disease (CVD) include blood pressure, smoking and cholesterol parameters. The use of total cholesterol for CVD risk prediction has been questioned, particularly for primary prevention. We evaluated whether glucose could be used instead of total cholesterol for prediction of fatal CVD using data with long follow-up. METHODS: We followed-up 6,095 men and women aged ≥16 years who participated 1977-79 in a community based health study and were anonymously linked with the Swiss National Cohort until the end of 2008. During follow-up, 727 participants died of CVD. Based on the ESC SCORE methodology (Weibull regression), we used age, sex, blood pressure, smoking, and fasting glucose or total cholesterol. The mean Brier score (BS), area under the receiver-operating characteristic curve (AUC) and integrated discrimination improvement (IDI) were used for model comparison. We validated our models internally using cross-validation and externally using another data set. RESULTS: In our models, the p-value of total cholesterol was 0.046, that of glucose was p < 0.001. The model with glucose had a slightly better predictive capacity (BS: 2216x10(-5) vs. 2232x10(-5); AUC: 0.9181 vs. 0.9169, IDI: 0.009 with p-value 0.026) and could well discriminate the overall risk of persons with high and low concentrations. The external validation confirmed these findings. CONCLUSIONS: Our study suggests that instead of total cholesterol glucose can be used in models predicting overall CVD mortality risk.
format Online
Article
Text
id pubmed-3599220
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35992202013-03-17 Blood glucose may be an alternative to cholesterol in CVD risk prediction charts Braun, Julia Bopp, Matthias Faeh, David Cardiovasc Diabetol Original Investigation BACKGROUND: Established risk models for the prediction of cardiovascular disease (CVD) include blood pressure, smoking and cholesterol parameters. The use of total cholesterol for CVD risk prediction has been questioned, particularly for primary prevention. We evaluated whether glucose could be used instead of total cholesterol for prediction of fatal CVD using data with long follow-up. METHODS: We followed-up 6,095 men and women aged ≥16 years who participated 1977-79 in a community based health study and were anonymously linked with the Swiss National Cohort until the end of 2008. During follow-up, 727 participants died of CVD. Based on the ESC SCORE methodology (Weibull regression), we used age, sex, blood pressure, smoking, and fasting glucose or total cholesterol. The mean Brier score (BS), area under the receiver-operating characteristic curve (AUC) and integrated discrimination improvement (IDI) were used for model comparison. We validated our models internally using cross-validation and externally using another data set. RESULTS: In our models, the p-value of total cholesterol was 0.046, that of glucose was p < 0.001. The model with glucose had a slightly better predictive capacity (BS: 2216x10(-5) vs. 2232x10(-5); AUC: 0.9181 vs. 0.9169, IDI: 0.009 with p-value 0.026) and could well discriminate the overall risk of persons with high and low concentrations. The external validation confirmed these findings. CONCLUSIONS: Our study suggests that instead of total cholesterol glucose can be used in models predicting overall CVD mortality risk. BioMed Central 2013-01-25 /pmc/articles/PMC3599220/ /pubmed/23351551 http://dx.doi.org/10.1186/1475-2840-12-24 Text en Copyright ©2013 Braun et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Investigation
Braun, Julia
Bopp, Matthias
Faeh, David
Blood glucose may be an alternative to cholesterol in CVD risk prediction charts
title Blood glucose may be an alternative to cholesterol in CVD risk prediction charts
title_full Blood glucose may be an alternative to cholesterol in CVD risk prediction charts
title_fullStr Blood glucose may be an alternative to cholesterol in CVD risk prediction charts
title_full_unstemmed Blood glucose may be an alternative to cholesterol in CVD risk prediction charts
title_short Blood glucose may be an alternative to cholesterol in CVD risk prediction charts
title_sort blood glucose may be an alternative to cholesterol in cvd risk prediction charts
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599220/
https://www.ncbi.nlm.nih.gov/pubmed/23351551
http://dx.doi.org/10.1186/1475-2840-12-24
work_keys_str_mv AT braunjulia bloodglucosemaybeanalternativetocholesterolincvdriskpredictioncharts
AT boppmatthias bloodglucosemaybeanalternativetocholesterolincvdriskpredictioncharts
AT faehdavid bloodglucosemaybeanalternativetocholesterolincvdriskpredictioncharts